Frontlight ResearchEarly access
Trial site
Innovative Clinical Research Institute
- 6running trials
- 9closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Metastatic breast cancer3 trials
- Chronic lymphocytic leukaemia2 trials
- Prostate cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Liver and biliary tract cancer1 trial
- Mantle cell lymphoma1 trial
- and 2 more
- Phase
- Phase 311 trials
- Phase 23 trials
- Phase 1/21 trial
- Status
- Completed7 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Terminated2 trials
- Lead sponsor
- Daiichi Sankyo3 trials
- AVM Biotechnology Inc1 trial
- Celgene1 trial
- Eleison Pharmaceuticals LLC.1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- and 8 more
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Recruiting
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Mantle cell lymphoma1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Terminated
Terminated
Completed
Completed
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026